[DOI] [PMC free article] [PubMed] [Google Scholar] Bergmark E, Calleman CJ, He F, Costa LG
As a triple incretin receptor agonist, it: Activates GLP-1 receptors , reducing appetite, slowing gastric emptying, and improving insulin secretion Activates GIP receptors , enhancing insulin response and potentially supporting fat metabolism Activates glucagon receptors , increasing energy expenditure and hepatic glucose output Whilst glucagon receptor activation increases hepatic glucose output, the net glycaemic effect of retatrutide is mitigated by the concurrent GLP-1 and GIP activity, resulting in overall improvements in glycaemic control in trial participants
#NerveFresh #NeuropathyRelief #NerveHealth #NaturalSupplements #PainRelief #InflammationSupport #CalmNerves #HerbalSupport #HealthyNerves #Wellness To view or add a comment, sign in Can we use all BP medicines in heart failure patients
Meta-analyses and systematic and narrative review articles were hand-searched for additional reports